D.A. Davidson & Co’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Sell
25,137
-220
-0.9% -$14.3K 0.01% 661
2026
Q1
$1.2M Buy
25,357
+120
+0.5% +$5.38K 0.01% 858
2025
Q4
$801K Buy
25,237
+305
+1% +$9.52K ﹤0.01% 972
2025
Q3
$702K Buy
24,932
+1,870
+8% +$56.6K ﹤0.01% 1000
2025
Q2
$848K Buy
23,062
+352
+2% +$12.2K 0.01% 862
2025
Q1
$892K Buy
22,710
+1,682
+8% +$75.8K 0.01% 808
2024
Q4
$977K Buy
21,028
+1,410
+7% +$63.7K 0.01% 779
2024
Q3
$886K Buy
19,618
+664
+4% +$31.6K 0.01% 806
2024
Q2
$934K Sell
18,954
-355
-2% -$14.5K 0.01% 757
2024
Q1
$662K Buy
19,309
+2,535
+15% +$91.5K 0.01% 882
2023
Q4
$618K Buy
16,774
+554
+3% +$12.8K 0.01% 869
2023
Q3
$329K Sell
16,220
-245
-1% -$5.38K ﹤0.01% 1055
2023
Q2
$337K Buy
16,465
+1,108
+7% +$16.6K ﹤0.01% 1059
2023
Q1
$232K Buy
15,357
+1,799
+13% +$39.7K ﹤0.01% 1174
2022
Q4
$323K Sell
13,558
-1,575
-10% -$45.7K ﹤0.01% 1020
2022
Q3
$533K Buy
15,133
+609
+4% +$25.9K 0.01% 792
2022
Q2
$508K Buy
14,524
+114
+0.8% +$4.04K 0.01% 818
2022
Q1
$712K Buy
14,410
+1,208
+9% +$66.9K 0.01% 754
2021
Q4
$1.02M Buy
13,202
+838
+7% +$86K 0.01% 651
2021
Q3
$1.32M Buy
12,364
+994
+9% +$114K 0.02% 549
2021
Q2
$1.51M Buy
11,370
+1,831
+19% +$213K 0.02% 511
2021
Q1
$1.18M Buy
+9,539
New +$1.45M 0.02% 545
2020
Q2
Sell
-9,753
Closed -$298K 1023
2020
Q1
$298K Buy
+9,753
New +$262K 0.01% 749

Other funds holding TWST

D.A. Davidson & Co's TWST Position: Q2 2026 in Review

D.A. Davidson & Co reduced its Twist Bioscience (TWST) stake by 0.87% in Q2 2026, selling an estimated $14.3K and leaving 25,137 shares worth $2.59M. The position accounts for 0.01% of the portfolio, ranked #661.

D.A. Davidson & Co first reported a position in TWST in Q1 2020 and has held it in 23 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • D.A. Davidson & Co held 25,137 shares of Twist Bioscience worth $2.59M as of Q2 2026.
  • D.A. Davidson & Co sold 220 Twist Bioscience shares in Q2 2026, an estimated $14.3K.
  • Twist Bioscience made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #661 holding.
  • D.A. Davidson & Co first reported a position in Twist Bioscience in Q1 2020 and has held it in 23 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.